Senseonics Holdings, Inc. (SENS)
NASDAQ: SENS · Real-Time Price · USD
7.18
-0.09 (-1.24%)
At close: Apr 28, 2026, 4:00 PM EDT
7.11
-0.07 (-0.97%)
After-hours: Apr 28, 2026, 7:57 PM EDT
Senseonics Holdings Employees
Senseonics Holdings had 130 employees as of December 31, 2025. The number of employees increased by 13 or 11.11% compared to the previous year.
Employees
130
Change (1Y)
13
Growth (1Y)
11.11%
Revenue / Employee
$271,208
Profits / Employee
-$531,638
Market Cap
300.15M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Viemed Healthcare | 1,382 |
| RxSight | 461 |
| Standard BioTools | 389 |
| Sight Sciences | 186 |
| Electromed | 180 |
| 908 Devices | 172 |
| ClearPoint Neuro | 172 |
| Profound Medical | 162 |
SENS News
- 4 days ago - Senseonics Announces European Launch of Eversense® 365, The World's First and Only One Year CGM System - GlobeNewsWire
- 6 weeks ago - First Ever Real-World Evidence of Eversense 365 Presented at ATTD Demonstrates Sustained Performance and Positive Impact Throughout One-Year of Wear - GlobeNewsWire
- 2 months ago - Senseonics Holdings Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 2 months ago - Sequel Med Tech and Senseonics Launch Transformative Combination of twiist™ and Eversense® 365 - GlobeNewsWire
- 2 months ago - Sequel Med Tech and Senseonics Launch Transformative Combination of twiist™ and Eversense® 365 - GlobeNewsWire
- 3 months ago - Senseonics Receives European Approval for Eversense 365, World's Longest-lasting Continuous Glucose Monitor - GlobeNewsWire
- 3 months ago - Senseonics Announces First Commercial Patients Using Eversense 365 Continuous Glucose Monitor (CGM) with twiist™ Automated Insulin Delivery (AID) System - GlobeNewsWire